Wegovy was developed for weight management, where clinical trials showed that higher doses (up to 2.4 mg) worked better for appetite suppression and weight loss
Both drugs can influence appetite by acting on GLP-1 receptors in the brain
In our view, at least three operational criteria should be considered: spatiotemporal ordering, mechanistic continuity, and ferroptosis specificity
Grntvedt GR, Sando SB, Lauridsen C, Brthen G, White LR, Salvesen , Aarsland D, Hessen E, Fladby T, Waterloo K, Scheffler K (2022) Association of Klotho protein levels and KL-VS heterozygosity with Alzheimer disease and amyloid and Tau burden
13 CoppleI
Numerous studies have found that GLP-1 agonists can be effective for weight loss, blood sugar management, and heart health, especially when combined with diet and lifestyle changes